Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D14SKB
|
|||
Drug Name |
MGTA-456
|
|||
Drug Type |
Cell therapy
|
|||
Indication | Metabolic disorder [ICD-11: 5C50-5D2Z] | Phase 2 | [1] | |
Company |
Magenta Therapeutics
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03406962) MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT). U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.